Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The cancer has been confirmed through a tissue sample (biopsy) as a specific type of stomach cancer (gastric adenocarcinoma) located in the upper or middle part of the stomach
- Age is between 20 and 80 years old
- The person is generally well enough to carry out daily activities with little to no limitation (as rated by a standard medical scale called ECOG, scored 0 or 1)
- The cancer is at an early to intermediate stage (Stage I–III), with no distant spread, as determined by stomach camera examination and abdominal scan
- Surgery to remove the entire stomach along with nearby lymph nodes is planned, and full removal of the cancer is considered achievable
- Written consent to participate in the trial has been provided
- No chemotherapy or radiotherapy has been received before surgery
Who may not be able to join:
- The cancer has spread extensively to many lymph nodes, or has grown into nearby structures beyond the stomach wall, based on standard staging assessment
- A previous history of chemotherapy, radiotherapy, immunotherapy, or targeted therapy
- Lymph nodes near the stomach are larger than 3 cm
- Previous stomach surgery, such as partial stomach removal or stomach-bowel bypass surgery
- More than one separate primary cancer present at the same time
- Serious existing health conditions, including poorly controlled heart, lung, kidney, or liver disease, uncontrolled high blood pressure, uncontrolled diabetes, or mental health disorders
- Emergency surgery is required due to a complication of the stomach cancer
- Significant internal scarring from previous abdominal surgery that could affect the procedure
- Removal of additional organs (beyond the stomach) is needed due to cancer spread or another condition
- People who are unable to communicate, are pregnant, or are planning to become pregnant
- Current participation in another clinical trial, or participation in one within the past 6 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dazhi Xu, PHD,MD, Fudan University
Phone: 021-64175590
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
3 year-DFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.